MedTrace Logo

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

NCT02806284 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2016-06-21

No results posted yet for this study

Summary

The purpose of this study is to determine wether skull trauma or neurosurgery affect the immune response to two vaccine types.

Conditions

Interventions

BIOLOGICAL

PPSV23, Act-HIB

described in "Arm description"

Sponsors & Collaborators

  • Uppsala University

    lead OTHER

Principal Investigators

  • Jan Sjölin, Professor · Uppsala University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2008-01-31
Completion
2010-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02806284 on ClinicalTrials.gov